Big Caring plans IPO debt repayment and pharmacy expansion
Pharmacy expansion needs cash beyond the shopfront. Big Caring’s proposed listing puts acquisition debt and distribution capacity alongside new outlets in the competition for capital.
The Malaysian pharmacy chain expects an offering of up to 2.45 billion Malaysian ringgit, according to a Wall Street Journal report cited by Free Malaysia Today. The reported timetable envisages a share sale in the final week of October and a Main Market listing by mid-November, with a valuation above 6 billion ringgit.
The proposed structure gives the business and its existing owners different rewards. Big Caring previously outlined 590.5 million new shares alongside 1.3 billion existing shares for sale. New shares bring capital into the company; sales of existing shares pay their owners. Expansion returns therefore depend on the company’s allocation of its own proceeds, after debt repayment and other calls on cash.
Acquisition debt competes with new outlets
Big Caring’s draft prospectus described plans to reduce acquisition debt and finance an automated distribution centre, according to The Edge. Borrowings totalled 1.3 billion ringgit at 31 January. The group’s average interest cost was 5.2 per cent at 30 June 2025, giving debt repayment a direct commercial purpose alongside the more visible programme of pharmacy openings.
Its acquisition history explains that priority. A term loan of 831.3 million ringgit formed the bulk of borrowings. The group bought Caring Pharmacy in 2023 and also paid 249.4 million ringgit for an 89.3 per cent stake in pharmaceutical distributor Medispec. The business being offered to investors combines a retail estate with distribution interests.
Repaying debt can improve profit without adding a customer or opening a pharmacy. It also reduces the financing burden carried into the next expansion cycle. That makes balance-sheet repair a credible use of equity, although it competes with cash available for premises, stock and systems. A successful listing can improve financial resilience before it accelerates physical growth.
The earnings benchmark is 143.02 million ringgit in net profit on revenue of 3.41 billion ringgit for the financial year ended 30 June 2025. Same-store sales growth reached 9.6 per cent, against 7.3 per cent in FY2024. Existing shops were contributing to growth, which gives the expansion case more substance than an acquisition tally alone.
The reported valuation demands attention to the quality of those earnings. Interest savings can lift profit, but recurring retail cash generation must carry the operating case. Investors paying for expansion need shops that earn satisfactory returns after rent, staffing and inventory costs. Suppliers face a related calculation: a larger customer offers volume, while tighter purchasing terms can absorb part of that benefit.
Automation must earn its place in the budget
Big Caring plans to open 40 to 50 outlets annually over the next three to five years, according to the draft prospectus account in The Edge. That programme increases the burden on replenishment as well as management. Reliable deliveries can protect sales while allowing a chain to control the stock tied up across its estate.
The group has also introduced an automated distribution centre and central corporate headquarters in Klang, Selangor. Sinar Harian described robotics, warehouse control systems and inventory management at the facility.
Those operating measures address a practical constraint on expansion. Faster picking can help a warehouse absorb additional demand; accurate picking reduces the scope for delivery errors. The financial return comes through labour productivity, dependable availability and inventory discipline. Automation spending earns its place when these gains outweigh the capital and running costs of the facility.
The group operates the Big Pharmacy and Caring Pharmacy chains and has about 670 stores nationwide. A broad estate gives purchasing negotiations commercial weight, but procurement power needs disciplined execution. Buying more stock on better terms can still consume cash if products move slowly. Distribution investment and store expansion work best when purchasing follows demand closely.
Rivals are buying established customer bases
Competition also comes from operators combining pharmacies with other healthcare services. Sarawak-based primary healthcare provider PMG Healthcare had 152 retail pharmacies, 28 medical clinics and eight dental clinics in The Edge’s account. Those categories describe different businesses, with different investment requirements; a combined healthcare network is a poor substitute for a pharmacy-only comparison.
PMG founder and chairman Dr Chieng King Chong estimated the cost of setting up a retail pharmacy at 500,000 ringgit in an interview with The Edge. That is a useful peer reference for the capital involved in an opening. Big Caring’s expansion economics still depend on its own fit-out costs, working capital and the speed at which each location builds sales.
Acquisitions offer an alternative route to customers, though the purchase price brings its own return hurdle. Big Caring’s debt repayment priority illustrates the continuing financial cost of buying scale. More aggressive bidding for established outlets would raise that hurdle; stronger sales and cash generation from existing shops would make further expansion easier to finance.
PMG has already used acquisitions to build its network, buying Johor-based AM PM Pharmacy and adding 46 outlets. It aspires to add 30 to 50 outlets annually, covering retail pharmacies and medical and dental clinics. Its expansion ambition therefore spans several services. The commercial attraction of buying an established pharmacy is access to an operating location and its customer relationships.
Chieng described the attraction of acquiring an established local presence in the same interview with The Edge: ‘The idea is to expand while leveraging outlets that have been set up. If we go into a particular area organically now, it will take a longer time to break even.’